Published • loading... • Updated
Rosen Law Firm Encourages Super Micro Computer, Inc. Investors to Inquire About Securities Class Action Investigation – SMCI
- On March 20, 2026 Rosen Law Firm announced an investigation on behalf of shareholders of Disc Medicine, Inc., citing allegations that the company may have issued misleading business information.
- Following the FDA's Complete Response Letter on February 13, 2026, the FDA said it could not approve Disc Medicine's NDA, and the stock fell 22%.
- Investors can join the prospective class by submitting an online form, calling Phillip Kim, Esq. toll-free at 866-767-3653, or emailing case@rosenlegal.com; The Rosen Law Firm has ranked top four since 2013, securing over $438 million in 2019.
- If you purchased Disc Medicine securities you may be entitled to compensation, as the Rosen Law Firm is preparing a class action seeking recovery through a contingency fee arrangement.
- Rosen urged investors to vet counsel because many firms issuing investor notices do not actually litigate securities class actions, advising investors considering joining class actions to select qualified counsel with a proven track record.
Insights by Ground AI
49 Articles
49 Articles
Coverage Details
Total News Sources49
Leaning Left6Leaning Right4Center20Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 20%
C 67%
13%
Factuality
To view factuality data please Upgrade to Premium

















